Biolegend, 423102, Zombie Aqua™ Fixable Viability Kit, 500tests

Zombie Aqua™ is an amine-reactive fluorescent dye that is non-permeant to live cells but permeant to cells with compromised membranes. Thus, it can be used to assess live vs. dead status of mammalian cells. Zombie Aqua™ is a polar, water-soluble dye providing very bright green fluorescence, making it suitable for use in multi-color detection.
500tests
Preparation: Zombie Aqua™ Fixable Viability Kit is composed of lyophilized Zombie Aqua™ dye and anhydrous DMSO. For reconstitution, pre-warm the kit to room temperature; add 100 µl of DMSO to one vial of Zombie Aqua™ dye and mix until fully dissolved. 100 tests = 1 vial of Zombie Aqua™ + DMSO, 500 tests = 5 vials of Zombie Aqua™ + DMSO.
Storage & Handling: Store kit at -20°C upon receipt. Do not open vials until needed. Once the DMSO is added to the Zombie Aqua™ dye, use immediately, or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.
Application: FC - Quality tested ICFC, ICC - Verified
Recommended Usage: Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometry, the suggested dilution is 1:100-1:1000 for 1-10 million cells. For immunofluorescence microscopy, the suggested dilution is 1:1000. It is recommended that the reagent be titrated for optimal performance for each application, as optimal dosage varies with cell type.
Excitation Laser: Violet Laser (405 nm)
Application Notes: Zombie Aqua™ dye is excited by the violet laser and has a maximum emission of 516 nm. If using in a multi-color panel design, filter optimization may be required depending on other fluorophores used. Zombie Aqua™ dye has similar emission to Brilliant Violet 510™. Standard Cell Staining Protocol: Prior to reconstitution, spin down the vial of lyophilized reagent in a microcentrifuge to ensure the reagent is at the bottom of the vial. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie Aqua™ dye and mix until fully dissolved Wash cells with PBS buffer (no Tris buffer and protein free). Dilute Zombie Aqua™ dye at 1:100-1000 in PBS. Resuspend 1-10 x 106 cells in diluted 100 µL Zombie Aqua™ solution. To minimize background staining of live cells, titrate the amount of dye and/or number of cells per 100 µL for optimal performance. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death. Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS. Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells. Incubate the cells at room temperature (or 4°C), in the dark, for 15-30 minutes. Wash one time with 2 mL BioLegend’s Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing serum or BSA. Continue performing antibody staining procedure as desired. Cells can be fixed with paraformaldehyde or methanol prior to permeabilization or can be analyzed without fixation. No-wash Sequential Staining Protocol: Wash cells with PBS buffer (no Tris buffer and protein free). For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie Aqua™ dye and mix until fully dissolved Determine the total µL volume of antibody cocktail previously titrated and optimized for the assay that will be added to each vial/well of cells based on a final volume of 100 µL. Subtract that antibody volume from the 100 µl total staining volume intended for the assay. In the remaining volume, dilute Zombie Aqua™ dye at 1:100-1000 in PBS as determined by prior optimization at that volume. For example, if you are adding 20 µL of antibody cocktail for a 100 µL total staining volume, use 80 µL of Zombie Aqua™ solution. Resuspend 1-10 x 106 cells in the appropriate volume of Zombie Aqua™ solution. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death. Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS. Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells. Incubate for 10-15 minutes at RT (or 4°C), protected from light. Without washing the cells, add the cell surface antibody cocktail and incubate for another 15-20 minutes. Add 1-2 mL Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing BSA or serum. Centrifuge to pellet. Continue with normal fixation and permeabilization procedure. If planning to skip fixation and analyze cells live, complete an additional wash step to minimize any unnecessary background of the live cells. Notes: If the cell type in use cannot tolerate a protein-free environment, then titrate the Zombie Aqua™ dye in the presence of the same amount of BSA/serum as will be present in the antibody staining procedure. A higher amount of Zombie Aqua™ may be required since the BSA/serum will react with and bind up some proportion of the Zombie Aqua™.
Additional Product Notes: View more applications data using this product to validate Veri-Cells™ lyophilized control cells and to study dendritic cell subsets.
Application References(PubMed link indicates BioLegend citation): Vom Berg J, et al. 2013. J Exp Med. 210:2803. PubMed Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed Price PJ, et al. 2014. J Virol. 88:10840. PubMed Schmid MA, et al. 2014. PLoS Pathog. 10:1004541. PubMed Cohen SB, et al. 2015. J Immunol. 194:210. PubMed Li J, et al. 2015. Cancer Res. 75:508. PubMed Price PJ, et al. 2015. J Immunol. 194:1164. PubMed Michelet X, et al. 2015. J Immunol. 194:2079. PubMed Tzeng A, et al. 2015. PNAS. 112:3320. PubMed Peres AG, et al. 2015. Infect Immun. 83:1587. PubMed Hansmann L, et al. 2015. Cancer Immunol Res. 3:650. PubMed
Product Citations: Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed Soon MSF, et al. 2020. Nat Immunol. 1.984027778. PubMed Lindner SE, et al. 2020. Immunohorizons. 0.356944444. PubMed Tasker C, et al. 2021. AAPS J. 23:26. PubMed Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed Kim J, et al. 2021. Front Cell Neurosci. 638098:15. PubMed Nuccitelli R, et al. 2017. J Immunother Cancer . 10.1186/s40425-017-0234-5. PubMed Kaczanowska S, et al. 2017. Cancer Res. . 10.1158/0008-5472.CAN-17-0653. PubMed Gálvez-Cancino F, et al. 2018. Oncoimmunology. 7:e1442163. PubMed Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed Ko J, et al. 2022. Nat Biotechnol. 40:1654. PubMed Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed Lutz EA, et al. 2022. Proc Natl Acad Sci U S A. 119:e2205983119. PubMed Bermea KC, et al. 2022. J Vis Exp. . PubMed Jia L, et al. 2022. Gut Microbes. 14:2117503. PubMed Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed Schuhmacher J, et al. 2022. Cells. 11:. PubMed Cruz-Reséndiz A, et al. 2022. Front Immunol. 13:1057499. PubMed Johnson SD, et al. 2022. Front Immunol. 13:1001727. PubMed Egli J, et al. 2022. MAbs. 14:2143009. PubMed Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed Cai Z, et al. 2023. Adv Sci (Weinh). 10:e2207155. PubMed Yang Y, et al. 2023. MBio. 14:e0328522. PubMed Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed Jun SH, et al. 2023. Nat Commun. 14:982. PubMed Fernandes S, et al. 2023. iScience. 26:106071. PubMed Aso K, et al. 2023. Nat Commun. 14:984. PubMed Medina S, et al. 2023. Water (Basel). 15:. PubMed Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed Xu K, et al. 2023. Elife. 12:. PubMed Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed Zhang J, et al. 2023. Front Immunol. 14:1091541. PubMed Harpur CM, et al. 2023. Clin Transl Immunology. 12:e1443. PubMed Pankhurst TE, et al. 2023. Cell Rep. 42:112310. PubMed Ahmed O, et al. 2023. Bioelectron Med. 9:6. PubMed Freitag PC, et al. 2023. Mol Ther Methods Clin Dev. 29:120. PubMed Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed Madar J, et al. 2023. Nat Commun. 14:2158. PubMed Consonni FM, et al. 2023. Front Immunol. 14:1168455. PubMed Fang Y, et al. 2023. Front Immunol. 14:1162004. PubMed Chaturvedi S, et al. 2023. Cell. 186:2036. PubMed Ximerakis M, et al. 2023. Nat Aging. 3:327. PubMed Liao Y, et al. 2023. ACS Omega. 8:15217. PubMed Menevse AN, et al. 2023. Acta Neuropathol Commun. 11:75. PubMed Liu JC, et al. 2023. Int J Mol Sci. 24:. PubMed Tang L, et al. 2023. Front Immunol. 14:1145441. PubMed Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed Malik JR, et al. 2023. Int J Mol Sci. 24:. PubMed Feng X, et al. 2023. Nat Commun. 14:3208. PubMed Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed Rueschenbaum S, et al. 2021. Front Immunol. 11:581352. PubMed Fantone K, et al. 2021. Pathogens. 10:. PubMed Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed Mo Y, et al. 2022. Front Immunol. 12:799896. PubMed Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed Castle AR, et al. 2022. PLoS One. 17:e0269342. PubMed Healy LM, et al. 2020. Glia. 68:811. PubMed Buchanan MW, et al. 2021. J Orthop Res. 39:1710. PubMed Eiva MA, et al. 2022. Eur J Immunol. 52:96. PubMed Duraiswamy J, et al. 2021. Cancer Cell. 39:1623. PubMed Herz J, et al. 2021. Neuron. 109:3609. PubMed Mills EL, et al. 2022. Cell Metab. 34:140. PubMed Miek L, et al. 2022. Immunology. 166:47. PubMed Wolf B, et al. 2022. Immunology. 166:380. PubMed Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed Shcheynikov N, et al. 2022. Hepatology. 76:1248. PubMed Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed Adam-Artigues A, et al. 2022. Sci Adv. 8:eabk2746. PubMed Yang K, et al. 2022. Sci Immunol. 7:eabn2888. PubMed Sugimoto S, et al. 2022. Nat Metab. 4:775. PubMed Ma T, et al. 2022. Elife. 11: . PubMed Benedetti V, et al. 2022. Sci Adv. 8:eabn3986. PubMed Guasconi L, et al. 2022. J Fungi (Basel). 8: . PubMed Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed Martínez-Sabadell A, et al. 2022. Cell Rep. 41:111430. PubMed Gao Y, et al. 2022. Cell Res. 32:1086. PubMed Dhar R, et al. 2022. Int J Mol Med. 50: . PubMed Balood M, et al. 2022. Nature. 611:405. PubMed Yoo HJ, et al. 2022. Cell Rep. 41:111598. PubMed Liang Y, et al. 2022. Theranostics. 12:7729. PubMed Rico-Llanos G, et al. 2022. Front Immunol. 13:1054962. PubMed Chen W, et al. 2022. Front Immunol. 13:1046426. PubMed Zia S, et al. 2022. Mol Neurodegener. 17:82. PubMed Zhuang L, et al. 2022. J Am Heart Assoc. 11:e027228. PubMed Pleuger C, et al. 2022. Elife. 11: . PubMed Shen W, et al. 2023. Dis Model Mech. 16: . PubMed Perveen R, et al. 2023. Hum Cell. 36:583. PubMed Krammer S, et al. 2022. Cells. 12: . PubMed Chan L, et al. 2022. Cells. 12: . PubMed Cousin N, et al. 2022. Cells. 12: . PubMed Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed Zhao Q, et al. 2023. Nutrients. 15: . PubMed Romine KA, et al. 2023. Leukemia. 37:580. PubMed Ai L, et al. 2023. Cell Discov. 9:9. PubMed Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed Gonçalves R, et al. 2023. iScience. 26:105972. PubMed Liu G, et al. 2023. Commun Biol. 6:102. PubMed Li H, et al. 2023. Front Immunol. 13:1056447. PubMed Lutz EA, et al. 2022. PNAS Nexus. 1:pgac244. PubMed Badenes M, et al. 2023. Life Sci Alliance. 6: . PubMed Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed Kang J, et al. 2023. JCI Insight. 8: . PubMed Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed Babl N, et al. 2023. Front Oncol. 13:1107484. PubMed Drummer C, et al. 2023. Front Immunol. 14:1113883. PubMed Li Y, et al. 2022. Brain Behav Immun. 101:1. PubMed Ryan CB, et al. 2022. Neurobiol Dis. 163:105608. PubMed Fahrner JE, et al. 2022. Cancer Discov. 12:958. PubMed Blair TC, et al. 2022. Life Sci Alliance. 5:. PubMed Seki SM, et al. 2020. Sci Signal. :13. PubMed Krausgruber T, et al. 2020. Nature. 583:296. PubMed Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed Michelet X, et al. 2015. J Immunol. 194:2079. PubMed Vanderleyden I, et al. 2020. Cell Rep. 30:611. PubMed Böttcher M, et al. 2018. Oncoimmunology. 7:e1445454. PubMed Jeevan-Raj B, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.071. PubMed Lam B, et al. 2021. Cell Rep. 37:109838. PubMed Ferrere G, et al. 2021. JCI Insight. 6:. PubMed Chaturvedi S, et al. 2022. Cell. 185:2086. PubMed Volta V, et al. 2021. Nat Commun. 12:6979. PubMed Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed Price P, et al. 2014. J Virol. 88:10840. PubMed Tzeng A, et al. 2015. Proc Natl Acad Sci U S A. 112:3320. PubMed Yamaguchi M, et al. 2016. J Leukoc Biol. 100: 131 - 141. PubMed Swee L, et al. 2016. Open Bio. 6: 160293. PubMed Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed Gálvez-Cancino F, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.06.041. PubMed Bailey S, et al. 2017. Nat Commun.. 10.1038/s41467-017-01867-9. PubMed Barry KC, et al. 2018. Nat Med. 24:1178. PubMed Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed Kobayashi T, et al. 2019. Cell. 176:982. PubMed Kiritsy MC, et al. 2021. Elife. 10:. PubMed Blake SJ, et al. 2021. Cell Rep Med. 2:100464. PubMed Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed Shin HS, et al. 2022. Sci Rep. 12:17605. PubMed Meyer Zu Natrup C, et al. 2022. J Clin Invest. Online ahead of print. PubMed Toomer G, et al. 2022. Viruses. 14:. PubMed Li LH, et al. 2020. Antiviral Res. 104929:183. PubMed Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed Gruber T, et al. 2020. JCI Insight. 5:00. PubMed Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed Neidleman J, et al. 2020. Elife. 9:00. PubMed Alberts-Grill N, et al. 2016. J Immunol. 197(12):4651-4662. PubMed Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed Torre S, et al. 2016. Nat Immunol. 10.1038/ni.3581. PubMed Bittner-Eddy P, et al. 2016. J Immunol. 197: 1435 - 1446. PubMed Berg J, et al. 2013. J Exp Med. 210:2803. PubMed Meehan S, et al. 2019. Commun Biol. 2:229. PubMed Tan L, et al. 2019. Cell Rep. 27:3657. PubMed Hartsough EJ, et al. 2019. Cell Death Dis. 10:281. PubMed Chattopadhyay A, et al. 2018. Sci Rep. 8:9032. PubMed Martrus G, et al. 2017. PLoS One.. 10.1371/journal.pone.0182532. PubMed Setten E, et al. 2022. Nat Commun. 13:6499. PubMed Liu Y, et al. 2022. Cancer Discov. :. PubMed Imbrechts M, et al. 2022. iScience. 25:104705. PubMed Munoz MA, et al. 2021. Elife. 10:. PubMed Gong W, et al. 2021. Oncoimmunology. 10:1997385. PubMed Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed van der Heide V, et al. 2022. Cell Rep. :110508. PubMed Witkowski M, et al. 2021. Nature. 600:295. PubMed Deng X, et al. 2021. Open Biol. 11:200340. PubMed Yu X, et al. 2021. Nature. 594:560. PubMed Park JJ, et al. 2021. Nat Commun. 12:1222. PubMed Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed Peres A, et al. 2015. Infect Immun . 83:1587. PubMed Yoshida N, et al. 2016. Nat Commun. 7: 12993. PubMed Fang V, et al. 2016. Nat Immunol. 18:15-25. PubMed Hagen SH, et al. 2020. Cell Rep. 33:108485. PubMed Pan H, et al. 2020. Mol Psychiatry. . PubMed Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed Botuyan MV, et al. 2018. Nat Struct Mol Biol. 25:591. PubMed Darzianiazizi M, et al. 2021. Cytokine X. 3:100053. PubMed Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed Mathur S, et al. 2021. JCI Insight. 6:. PubMed Pedersen JG, et al. 2021. Front Microbiol. 12:763030. PubMed Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed Bresque M, et al. 2022. J Biol Chem. :101711. PubMed Peng Q, et al. 2022. EBioMedicine. 77:103904. PubMed Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed Ruetsche D, et al. 2022. Cells. 11:. PubMed Martínez-Sabadell A, et al. 2022. STAR Protoc. 3:101712. PubMed Tu X, et al. 2022. Nat Commun. 13:6977. PubMed Amberg N, et al. 2016. J Invest Dermatol. 136:2140-2149. PubMed Cunningham C, et al. 2016. PLoS Pathog. 12: 1005356. PubMed Schmitt N, et al. 2015. Mol Cancer Ther. 14: 2103-2111. PubMed Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed Grozio A, et al. 2019. Nat Metab. 1:47. PubMed Ramsey HE, et al. 2018. Cancer Discov. 8:1566. PubMed Parameswaran P, et al. 2017. Cell Host Microbe. 10.1016/j.chom.2017.08.003. PubMed Chen Z, et al. 2022. Theranostics. 12:6242. PubMed Tang JJ, et al. 2022. Cell Rep. 39:110987. PubMed Luo X, et al. 2021. J Biol Chem. 297:101098. PubMed Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed Denkers S 2015. J Immunol. 195: 2754-2762. PubMed Garcia-Bates T, et al. 2016. J Immunol. 196: 2870 - 2878. PubMed Davidson S, et al. 2016. EMBO Mol Med. 8: 1099 - 1112. PubMed Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed Montes de Oca M, et al. 2020. PLoS Pathog. 16:e1008994. PubMed Jordan PM, et al. 2020. Cell Rep. 33:108247. PubMed Doty DT, et al. 2020. Int J Mol Sci. 21:00. PubMed Dillon SM, et al. 2020. Bio Protoc. e3486:10. PubMed Pantelyushin S, et al. 2021. Cancers (Basel). :13. PubMed Ceholski D, et al. 2017. Stem Cell Res. 10.1016/j.scr.2017.06.015. PubMed Metzemaekers M, et al. 2017. Int J Mol Sci. 10.3390/ijms18071513. PubMed Tien S, et al. 2017. PLoS One. 10.1371/journal.pone.0181338. PubMed Valbuena Perez JV, et al. 2020. Aging Cell. 19:e13156. PubMed Sellau J, et al. 2020. Nat Commun. 2.860416667. PubMed Alsaleh G, et al. 2020. Elife. 9: . PubMed Stuani L, et al. 2021. J Exp Med. 218:. PubMed Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed Yang K, et al. 2022. J Clin Invest. 132:. PubMed Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed Tang Y, et al. 2021. Cancer Discov. 11:3142. PubMed Borst L, et al. 2022. Int J Cancer. 150:688. PubMed Alvisi G, et al. 2022. Methods Mol Biol. 2559:243. PubMed Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed Audiger C, et al. 2020. J Immunol. 205:121. PubMed Fernandez-Castaneda A, et al. 2020. Acta Neuropathol. 139:365. PubMed Köchl R, et al. 2020. Elife. 9:00. PubMed Honarpisheh P, et al. 2020. J Neuroinflammation. 0.9625. PubMed OlguÍn-Alor R, et al. 2016. PLoS One. 11:e0167813. PubMed Crisci E, et al. 2016. J Virol. 90: 4939 - 4950. PubMed Hansmann L, et al. 2015. Cancer Immunol Res. 3:650. PubMed Chakraborty A, et al. 2020. Cell Rep. 32:108179. PubMed Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed Kruse S, et al. 2018. Oncoimmunology. 8:e1524694. PubMed Louveau A, et al. 2018. Curr Protoc Immunol. 121:1. PubMed Wilmore JR et al. 2018. Cell host & microbe. 23(3):302-311 . PubMed Joshi N and Werner S. 2017. PLoS One. 10.1371/journal.pone.0187162. PubMed Natoli M, et al. 2022. J Immunother Cancer. 10:. PubMed Wang Z, et al. 2022. Nat Commun. 13:5447. PubMed Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed Romine KA, et al. 2021. Cancer Discov. . PubMed Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed Li Y, et al. 2021. Brain Behav Immun. 91:267. PubMed Karagianni AE, et al. 2021. Sci Rep. 11:14292. PubMed Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed Amanat F, et al. 2021. Cell. 184:3936. PubMed Acharya A, et al. 2020. J Virol. 95:e01657. PubMed Yang Y, et al. 2016. Nucleic Acids Res. 44: 4174 - 4188. PubMed Coria L, et al. 2016. J Immunol. 196: 4014 - 4029. PubMed Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed Kallert S, et al. 2017. Nature Communications. 10.1038/ncomms15327. PubMed Rechtien A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.08.023. PubMed Yamazaki T, et al. 2020. Oncoimmunology. 9:1721810. PubMed Guo J, et al. 2019. Cancer Immunol Res. 1.349305556. PubMed Xing J, et al. 2021. Nat Commun. 12:2681. PubMed Hildebrand KM, et al. 2021. PLoS One. 16:e0253864. PubMed Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed Hu H, et al. 2021. Cancer Immunol Res. 9:1298. PubMed Breen EC, et al. 2022. iScience. 25:104488. PubMed Giesen D, et al. 2020. Clin Cancer Res. 26:3999. PubMed Tsang M, et al. 2020. Am J Pathol. 190:206. PubMed Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed Brugat T, et al. 2017. Nat Microbiol. 2:16276. PubMed Andriessen E, et al. 2016. EMBO Mol Med. 8(12):1366-1379. PubMed Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed Schmid M, et al. 2016. PLoS One. 12: 1005676. PubMed Contreras F, et al. 2016. J Immunol. 196: 4143 - 4149. PubMed Larmonier C, et al. 2016. J Biol Chem. 291: 8918-8930. PubMed Lim X, et al. 2016. Proc Natl Acad Sci U S A. 113: 1498 - 1505. PubMed Carmona SJ, et al. 2020. Oncoimmunology. 9:1737369. PubMed Haloul M, et al. 2019. Sci Rep. 9:14050. PubMed Engelbertsen D, et al. 2019. Sci Rep. 9:10608. PubMed Freire DM, et al. 2019. Mol Cell. 73:1282. PubMed Scarneo SA, et al. 2022. Sci Rep. 12:18091. PubMed Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed , et al. 2021. Eur J Immunol. 51:2708. PubMed Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed Shen J, et al. 2022. Front Immunol. 13:762580. PubMed Momin N, et al. 2022. Nat Commun. 13:109. PubMed Cohen S, et al. 2015. J Immunol. 194:210. PubMed Price P, et al. 2015. J Immunol. 194:1164. PubMed Chattopadhyay A, et al. 2016. J Lipid Res. 57: 832 - 847. PubMed Dutzan N, et al. 2017. Immunity. 46(1):133-147. PubMed Coden ME, et al. 2020. J Immunol. 204:438. PubMed James KR, et al. 2020. Nat Immunol. 1.113194444. PubMed Lewandowski JP, et al. 2020. Genome Biol. 1.039583333. PubMed Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed Fragniere AMC, et al. 2019. Sci Rep. 9:2288. PubMed Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed Neal JT, et al. 2018. Cell. 175:1972. PubMed Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed Zebertavage LK, et al. 2020. Sci Rep. 10:7376. PubMed Sabree SA, et al. 2021. J Immunother Cancer. 9: . PubMed Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed Pan W, et al. 2021. J Immunol. 206:1719. PubMed Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed Alameh MG, et al. 2021. Immunity. 54:2877. PubMed Bankova AK, et al. 2022. Transplant Cell Ther. . PubMed Sinha SR, et al. 2020. Cell Host Microbe. 27:659. PubMed Bullard BL, et al. 2022. NPJ Vaccines. 7:65. PubMed Rossignol J, et al. 2022. iScience. 25:104353. PubMed Karagianni A, et al. 2022. Front Oncol. 12:929498. PubMed Castro JT, et al. 2022. Nat Commun. 13:4831. PubMed Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed Ritzel RM, et al. 2021. Glia. 69:746. PubMed Parayath NN, et al. 2020. Nat Commun. 4.680555556. PubMed Wang L, et al. 2020. EMBO J. 39:e104514. PubMed Ryan P, et al. 2016. Proc Natl Acad Sci U S A. 113(50):14378-14383. PubMed LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed Tron AE, et al. 2018. Nat Commun. 9:5341. PubMed Collin R, et al. 2017. J Immunol. 10.4049/jimmunol.1600789. PubMed Teng Y, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0485-0. PubMed Huo Y, et al. 2022. Front Immunol. 13:983116. PubMed Clark GC, et al. 2022. Front Oncol. 12:913656. PubMed Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed Rocha-Resende C, et al. 2021. J Mol Cell Cardiol. 157:98. PubMed Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed Barington L, et al. 2022. Cells. 11:. PubMed Bendtsen SK, et al. 2022. Oncoimmunology. 11:2026020. PubMed Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed Huo Y, et al. 2021. BMC Genomics. 22:145. PubMed Madsen A, et al. 2020. Immunity. 53:852. PubMed Schmid M, Harris E 2014. PLoS Pathog. 10:1004541. PubMed Yoder A, et al. 2017. PLoS Pathog. 13(2):e1006226. PubMed Davey M, et al. 2017. Nat Commun. 10.1038/ncomms14760. PubMed Fang H, et al. 2020. Nat Commun. 4.661805556. PubMed Hagen SH, et al. 2021. STAR Protocols. 2(3):100641. PubMed Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed Becker JR, et al. 2018. Nat Commun. 9:5406. PubMed Suan D et al. 2017. Immunity. 47(6):1142-1153 . PubMed Daemen S, et al. 2021. STAR Protoc. 2:100511. PubMed Santos NB, et al. 2021. PLoS Pathog. 17:e1009381. PubMed Miller JE, et al. 2021. JCI Insight. 6:. PubMed Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed Lee GJ, et al. 2022. Oncoimmunology. 11:2015170. PubMed Andriessen EMMA, et al. 2021. EMBO Mol Med. 13:e11754. PubMed Shibata H, et al. 2021. Oncoimmunology. 10:1958589. PubMed Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed Li J, et al. 2022. Nat Commun. 13:4032. PubMed Taylor D, et al. 2022. Front Immunol. 13:936129. PubMed Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed Concha-Benavente F, et al. 2016. Cancer Res . 76: 1031 - 1043. PubMed Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed Ogrinc Wagner A, et al. 2019. PLoS One. 14:e0210998. PubMed Zwick M, et al. 2019. Front Immunol. 10:222. PubMed Li H, et al. 2022. Front Immunol. 13:946202. PubMed Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed McCallion A, et al. 2022. Front Immunol. 13:961599. PubMed Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed Alice AF, et al. 2021. Sci Rep. 11:16347. PubMed Singh AK, et al. 2022. Nat Commun. 13:878. PubMed Kumar S, et al. 2022. Gut. . PubMed Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed Manouchehri N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed Nylund P, et al. 2021. Cell Death Dis. 12:167. PubMed Hofmann J, et al. 2021. Front Immunol. 11:599495. PubMed Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed de Winde CM, et al. 2021. J Cell Sci. 134: . PubMed Leong Y, et al. 2016. Nat Immunol. 17:1187-1196. PubMed Ohs I, et al. 2016. Nat Commun. 7:13708. PubMed Schuldt N, et al. 2017. The Journal of Immunology. 10.4049/jimmunol.1700406. PubMed Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed Dawson NA, et al. 2019. JCI Insight. 4:6. PubMed Vigeland CL, et al. 2019. Physiol Rep. 7:e14019. PubMed Lu YJ, et al. 2021. Cell Rep. 36:109696. PubMed Arenas EJ, et al. 2021. Nat Commun. 12:1237. PubMed Rodriguez E, et al. 2021. Cancers (Basel). 13:. PubMed Dholakia J, et al. 2022. Gynecol Oncol. 164:170. PubMed Wegrecki M, et al. 2022. Nat Commun. 13:3872. PubMed Peng Z, et al. 2022. J Neuroinflammation. 19:186. PubMed Brockman QR, et al. 2022. JCI Insight. :. PubMed Lee SH, et al. 2022. Nat Commun. 13:5461. PubMed Abdelsamed HA, et al. 2020. Nat Immunol. 1.276388889. PubMed Rocha-Resende C, et al. 2020. JCI Insight. 5:00. PubMed Luo X, et al. 2020. J Clin Invest. 130:1635. PubMed Peter Morawski, Chen-Feng Qi, Silvia Boll 2017. Sci Rep. 7:40838. PubMed Antsiferova M, et al. 2017. EMBO Mol Med. 9(1):27-45. PubMed Ju X, et al. 2016. J Immunol. 197(12):4613-4625. PubMed Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed Gouwy M, et al. 2016. PLoS One. 11:e0166006. PubMed McGuire V, et al. 2016. Sci Rep. 6:31159. PubMed Comte D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9321 - 9326. PubMed Carpenter S, et al. 2016. PLoS Pathog. 12: 1005380. PubMed Jerby–Arnon L, et al. 2018. Cell. 175:984. PubMed Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed Ghezraoui H, et al. 2018. Nature. 560:122. PubMed Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed Li M, et al. 2021. Mol Biomed. 2:41. PubMed Milich LM, et al. 2021. J Exp Med. 218:. PubMed Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed Fucà G, et al. 2021. J Immunother Cancer. 9:. PubMed Egedal JH, et al. 2021. Mucosal Immunol. 14:1203. PubMed Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed Martini E, et al. 2016. Cell Rep. 14:1062-1073. PubMed Weiss G, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.104. PubMed Neidleman J, et al. 2017. PLoS Pathog. 13(2):e1006163. PubMed Sam J, et al. 2020. Front Oncol. 10:575737. PubMed Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed Blair TC, et al. 2020. J Immunol. 204:3416. PubMed Dhimolea E, et al. 2021. Cancer Cell. 39:240. PubMed Li Y, et al. 2022. Theranostics. 12:5364. PubMed Burger ML, et al. 2021. Cell. 184:4996. PubMed Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed Salahudeen AA, et al. 2020. bioRxiv. . PubMed Farooq F, et al. 2016. Sci Rep. 6:27944. PubMed Li Y, et al. 2020. Theranostics. 10:11376. PubMed Tomlinson JE, et al. 2018. J Neuroinflammation. 0.753472222. PubMed Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed Yuan C, et al. 2018. iScience. 11:13. PubMed Tiberti S, et al. 2022. Nat Commun. 13:6752. PubMed Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed Lau P, et al. 2022. Cell Mol Immunol. :. PubMed van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed Singh SS, et al. 2022. Clin Transl Immunology. 11:e1396. PubMed Sakamoto K, et al. 2022. STAR Protoc. 3:101052. PubMed Verma M, et al. 2021. J Exp Med. 218:. PubMed Van Winkle JA, et al. 2020. J Virol. 94:. PubMed Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed Krogmann A, et al. 2016. PLoS One. 11: 0146326. PubMed Johns S, et al. 2016. Circ Res . 119: 210 - 221. PubMed Cho SX, et al. 2020. Nat Commun. 4.481944444. PubMed Filippo Buono M, et al. 2020. Cells. 9:00. PubMed Dai H, et al. 2017. J Immunol. 10.4049/jimmunol.1700418. PubMed Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed Friedrich V, et al. 2021. Gut Microbes. 13:1. PubMed Jiang M, et al. 2021. Front Pharmacol. 12:657486. PubMed Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed Schaller MA, et al. 2021. JCI Insight. 6:e148003. PubMed Pan L, et al. 2021. Stem Cell Res Ther. 12:496. PubMed Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed Xu L, et al. 2022. Front Immunol. 13:841141. PubMed Spath S, et al. 2022. iScience. 25:104998. PubMed Schreurs RRCE, et al. 2021. Mucosal Immunology. 14(3):605-614. PubMed Workel HH, et al. 2020. Int J Mol Sci. 21:00. PubMed Laczkó D, et al. 2020. Immunity. 53:724. PubMed Salahudeen AA, et al. 2020. Nature. 588:670. PubMed Hatfield J, Brown M 2015. Cell Immunol. . PubMed Li J, et al. 2015. Cancer Res. 75:508. PubMed Binnewies M, et al. 2019. Cell. 177:556. PubMed Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed Kimura K, et al. 2018. Nat Commun. 9:17. PubMed Wang CJH, et al. 2022. J Biol Chem. :102714. PubMed Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed Wang H, et al. 2022. J Cancer. 13:2126. PubMed Bouchard G, et al. 2022. Cancer Res. 82:648. PubMed Khurana P, et al. 2021. Front Immunol. 12:700374. PubMed Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed Chakraborty A, et al. 2021. Biomaterials. 273:120796. PubMed Feng Y, et al. 2022. EClinicalMedicine. 43:101226. PubMed Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed Tee YC, et al. 2021. FASEB Bioadv. 3:829. PubMed Xia L, et al. 2021. Cancer Immunol Res. 9:707. PubMed Chiou SH, et al. 2021. Immunity. 54:586. PubMed
Biology Area: Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID: NA
Regulatory Status: RUO
Other Names: Fixable Dye, Fixable Viability Dye, Dead, Apoptosis
Q: Is Zombie Aqua™ an equivalent to cell labeling and tracer dyes such as CellTrace™ Violet and CFSE?
A: Zombie Aqua™ is not a direct equivalent to such dyes because their mechanism of action and scope of application are entirely different.
Q: I am concerned about the spillover I am observing from the Zombie dye into its neighboring channels.
A: Rule of thumb with Zombie dyes is to titrate them down as much as possible to fit your application. This should potentially help with spillover. Secondly, Zombie positive events represent dead cells and are typically gated out from analysis.
Q: How does the performance of your Zombie dye compare with competitors?
A: Zombie dyes have been tested against other leading competitors' fixable viability kits and given comparable results. We also highly recommend that you titrate down the amount of each dye used in order to best match the negative signals of your unstained sample and MFI- (mean fluorescence intensity) stained samples.
Q: Can I use methanol/ethanol for fixation after using a Zombie dye?
A: Yes, most fixation reagents are fine to be used with Zombie dyes. However, it should be noted that Zombie dyes can still be sensitive to reactive oxygen species. Light exposure or reagents with hydrogen peroxide can lead to free radical formation, affecting fluorescence.
Q: Can Zombie be used to determine bacteria, yeast viability?
A: We have not tested in house bacterial or